Eligibility Diabetes Mellitus, Type 2 NCT00380445

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
must be able to complete a 3-week wash-out of current anti-diabetic medication
Description

Antidiabetics | Washout Period Completion Able

Data type

boolean

Alias
UMLS CUI [1]
C0935929
UMLS CUI [2,1]
C1710661
UMLS CUI [2,2]
C0205197
UMLS CUI [2,3]
C0085732
cannot take any medications which may alter gastric motility except for cardiac medication at a stable dose
Description

Pharmaceutical Preparations Resulting in Altered gastric motility | Cardiac agent Dose Stable

Data type

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0332294
UMLS CUI [1,3]
C0548822
UMLS CUI [2,1]
C0280076
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0205360
must discontinue beta-blockers and lipid lowering drugs
Description

Adrenergic beta-1 Receptor Antagonists To be stopped | Antilipemic agent To be stopped

Data type

boolean

Alias
UMLS CUI [1,1]
C0304516
UMLS CUI [1,2]
C1272691
UMLS CUI [2,1]
C0003367
UMLS CUI [2,2]
C1272691
blood glucose criteria must be met
Description

Blood Glucose criteria Fulfill

Data type

boolean

Alias
UMLS CUI [1,1]
C0005802
UMLS CUI [1,2]
C0243161
UMLS CUI [1,3]
C1550543
bmi in the range 30-35
Description

Body mass index

Data type

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of type 1 diabetes, diabetes resulting from pancreatic injury, or secondary forms of diabetes
Description

Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus Due to Injury of pancreas | Secondary diabetes mellitus

Data type

boolean

Alias
UMLS CUI [1]
C0011854
UMLS CUI [2,1]
C0011849
UMLS CUI [2,2]
C0678226
UMLS CUI [2,3]
C0273163
UMLS CUI [3]
C0271640
need for insulin within 3 months or patients on thiazolidinediones
Description

Insulin Patient need for | Thiazolidinediones

Data type

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C0686904
UMLS CUI [2]
C1257987
patients taking a sulfonylurea or metformin who cannot safely discontinue medication for the duration of the study
Description

Sulfonylurea | Metformin | Pharmaceutical Preparations Discontinue Unable

Data type

boolean

Alias
UMLS CUI [1]
C0038766
UMLS CUI [2]
C0025598
UMLS CUI [3,1]
C0013227
UMLS CUI [3,2]
C1444662
UMLS CUI [3,3]
C1299582
significant concomitant disease or complications of diabetes
Description

Comorbidity | Complications of Diabetes Mellitus

Data type

boolean

Alias
UMLS CUI [1]
C0009488
UMLS CUI [2]
C0342257
patients with any history of gastrointestinal surgery or positive gastrointestinal symptons
Description

Gastrointestinal Surgical Procedure | Gastrointestinal symptom Positive

Data type

boolean

Alias
UMLS CUI [1]
C0524722
UMLS CUI [2,1]
C0426576
UMLS CUI [2,2]
C1514241
high tryglycerides as defined by the protocol
Description

Triglycerides High

Data type

boolean

Alias
UMLS CUI [1,1]
C0041004
UMLS CUI [1,2]
C0205250
smokers who cannot abstain from smoking during the treatment periods
Description

Tobacco use Abstinence Unable

Data type

boolean

Alias
UMLS CUI [1,1]
C0543414
UMLS CUI [1,2]
C3843422
UMLS CUI [1,3]
C1299582

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT00380445

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Antidiabetics | Washout Period Completion Able
Item
must be able to complete a 3-week wash-out of current anti-diabetic medication
boolean
C0935929 (UMLS CUI [1])
C1710661 (UMLS CUI [2,1])
C0205197 (UMLS CUI [2,2])
C0085732 (UMLS CUI [2,3])
Pharmaceutical Preparations Resulting in Altered gastric motility | Cardiac agent Dose Stable
Item
cannot take any medications which may alter gastric motility except for cardiac medication at a stable dose
boolean
C0013227 (UMLS CUI [1,1])
C0332294 (UMLS CUI [1,2])
C0548822 (UMLS CUI [1,3])
C0280076 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
Adrenergic beta-1 Receptor Antagonists To be stopped | Antilipemic agent To be stopped
Item
must discontinue beta-blockers and lipid lowering drugs
boolean
C0304516 (UMLS CUI [1,1])
C1272691 (UMLS CUI [1,2])
C0003367 (UMLS CUI [2,1])
C1272691 (UMLS CUI [2,2])
Blood Glucose criteria Fulfill
Item
blood glucose criteria must be met
boolean
C0005802 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
Body mass index
Item
bmi in the range 30-35
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus Due to Injury of pancreas | Secondary diabetes mellitus
Item
history of type 1 diabetes, diabetes resulting from pancreatic injury, or secondary forms of diabetes
boolean
C0011854 (UMLS CUI [1])
C0011849 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0273163 (UMLS CUI [2,3])
C0271640 (UMLS CUI [3])
Insulin Patient need for | Thiazolidinediones
Item
need for insulin within 3 months or patients on thiazolidinediones
boolean
C0021641 (UMLS CUI [1,1])
C0686904 (UMLS CUI [1,2])
C1257987 (UMLS CUI [2])
Sulfonylurea | Metformin | Pharmaceutical Preparations Discontinue Unable
Item
patients taking a sulfonylurea or metformin who cannot safely discontinue medication for the duration of the study
boolean
C0038766 (UMLS CUI [1])
C0025598 (UMLS CUI [2])
C0013227 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
C1299582 (UMLS CUI [3,3])
Comorbidity | Complications of Diabetes Mellitus
Item
significant concomitant disease or complications of diabetes
boolean
C0009488 (UMLS CUI [1])
C0342257 (UMLS CUI [2])
Gastrointestinal Surgical Procedure | Gastrointestinal symptom Positive
Item
patients with any history of gastrointestinal surgery or positive gastrointestinal symptons
boolean
C0524722 (UMLS CUI [1])
C0426576 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
Triglycerides High
Item
high tryglycerides as defined by the protocol
boolean
C0041004 (UMLS CUI [1,1])
C0205250 (UMLS CUI [1,2])
Tobacco use Abstinence Unable
Item
smokers who cannot abstain from smoking during the treatment periods
boolean
C0543414 (UMLS CUI [1,1])
C3843422 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])